case_images: PMC8205574_01
case_images: CT neck showing encasement and marked narrowing of the left cervical internal carotid artery.
case_images: CRIONM2021-8856167.001.jpg
case_images: PMC8205574_01_CRIONM2021-8856167.001.jpg
case_images: fig1
case_images: Encasement and marked narrowing of the left cervical internal carotid artery were noted (Figure 1).
case_images: MRI of the neck with and without contrast showing a mass lesion centered within the left jugular foramen, appearing mildly increased in size. The size was 20 mm in maximal dimension as opposed to 17 mm compared to previous imaging 6 months prior.
case_images: CRIONM2021-8856167.002.jpg
case_images: PMC8205574_01_CRIONM2021-8856167.002.jpg
case_images: fig2
case_images: The size was 20 mm in maximal dimension as opposed to 17 mm compared to previous imaging 6 months prior (Figure 2).
case_images: MRI of the thoracic and lumbar spine showing multiple osseous lesions.
case_images: CRIONM2021-8856167.003.jpg
case_images: PMC8205574_01_CRIONM2021-8856167.003.jpg
case_images: fig3
case_images: Her MRI of the thoracic and lumbar spine showed multiple osseous lesions (Figure 3).
case_images: PET/CT GA-68 dotatate scan showing multiple scattered metastatic lesions to the spine with subtle increase in size and conspicuity of a few sacral and lumbar lesions.
case_images: CRIONM2021-8856167.004.jpg
case_images: PMC8205574_01_CRIONM2021-8856167.004.jpg
case_images: fig4
case_images: She underwent a PET/CT GA-68 dotatate scan in the spring of 2019 which revealed multiple scattered metastatic lesions to the spine with subtle increase in size and conspicuity of a few sacral and lumbar lesions (Figure 4).
case_images: PET/CT GA-68 dotatate scan showing a modest response to therapy with no new lesions identified.
case_images: CRIONM2021-8856167.005.jpg
case_images: PMC8205574_01_CRIONM2021-8856167.005.jpg
case_images: fig5
case_images: December 2019 showed a modest response to therapy with no new lesions identified while previously these lesions had been progressively getting worse (Figure 5). During the most recent oncology follow-up visit in February 2020, the patient reports some continued fatigue that is beginning to improve.